473 related articles for article (PubMed ID: 20413641)
1. Radioprotectors and mitigators of radiation-induced normal tissue injury.
Citrin D; Cotrim AP; Hyodo F; Baum BJ; Krishna MC; Mitchell JB
Oncologist; 2010; 15(4):360-71. PubMed ID: 20413641
[TBL] [Abstract][Full Text] [Related]
2. Radioprotective agents for radiation therapy: future trends.
Johnke RM; Sattler JA; Allison RR
Future Oncol; 2014 Dec; 10(15):2345-57. PubMed ID: 25525844
[TBL] [Abstract][Full Text] [Related]
3. Role of drugs in the prevention and amelioration of radiation induced toxic effects.
Patyar RR; Patyar S
Eur J Pharmacol; 2018 Jan; 819():207-216. PubMed ID: 29221951
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizers, radioprotectors, and radiation mitigators.
Raviraj J; Bokkasam VK; Kumar VS; Reddy US; Suman V
Indian J Dent Res; 2014; 25(1):83-90. PubMed ID: 24748306
[TBL] [Abstract][Full Text] [Related]
5. Radioprotectors - the evergreen topic.
Kuntić VS; Stanković MB; Vujić ZB; Brborić JS; Uskoković-Marković SM
Chem Biodivers; 2013 Oct; 10(10):1791-803. PubMed ID: 24130023
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Bourgier C; Levy A; Vozenin MC; Deutsch E
Cancer Metastasis Rev; 2012 Dec; 31(3-4):699-712. PubMed ID: 22706781
[TBL] [Abstract][Full Text] [Related]
7. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
8. Radioprotection of normal tissue cells.
Maier P; Wenz F; Herskind C
Strahlenther Onkol; 2014 Aug; 190(8):745-52. PubMed ID: 24638269
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic approaches to radiation protection.
Brizel DM
J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
[TBL] [Abstract][Full Text] [Related]
10. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters.
Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M
Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213
[TBL] [Abstract][Full Text] [Related]
11. Does amifostine have a role in chemoradiation treatment?
Brizel DM; Overgaard J
Lancet Oncol; 2003 Jun; 4(6):378-81. PubMed ID: 12788413
[TBL] [Abstract][Full Text] [Related]
12. Radioprotective countermeasures for radiation injury (Review).
Liu L; Liang Z; Ma S; Li L; Liu X
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799170
[TBL] [Abstract][Full Text] [Related]
13. Radioprotectors.org: an open database of known and predicted radioprotectors.
Aliper AM; Bozdaganyan ME; Sarkisova VA; Veviorsky AP; Ozerov IV; Orekhov PS; Korzinkin MB; Moskalev A; Zhavoronkov A; Osipov AN
Aging (Albany NY); 2020 Aug; 12(15):15741-15755. PubMed ID: 32805729
[TBL] [Abstract][Full Text] [Related]
14. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation.
Zivkovic Radojevic M; Milosavljevic N; Miladinovic TB; Janković S; Folic M
Int J Radiat Biol; 2023; 99(4):594-603. PubMed ID: 35930681
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
Mell LK; Movsas B
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1341-50. PubMed ID: 18798703
[TBL] [Abstract][Full Text] [Related]
16. Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.
Ryan JL; Krishnan S; Movsas B; Coleman CN; Vikram B; Yoo SS
Radiat Res; 2011 Nov; 176(5):688-91. PubMed ID: 21883022
[No Abstract] [Full Text] [Related]
17. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
Capizzi RL; Oster W
Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of natural radioprotectors.
Mun GI; Kim S; Choi E; Kim CS; Lee YS
Arch Pharm Res; 2018 Nov; 41(11):1033-1050. PubMed ID: 30361949
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic approaches to protection against radiation-induced lethality and other damage.
Weiss JF
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1473-8. PubMed ID: 9467066
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapeutic studies with amifostine (Ethyol).
Wasserman TH
Semin Oncol; 1994 Oct; 21(5 Suppl 11):21-5. PubMed ID: 7973775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
